featured
CV Risk With Ranibizumab for Wet AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular Risk in Patients Receiving Ranibizumab for Exudative Age-Related Macular Degeneration: A Nationwide Self-Controlled Case-Series Study
Br J Ophthalmol 2020 Jun 10;[EPub Ahead of Print], HL Jeon, SJ Byun, NL Pratt, J Sultana, SJ Park, JY ShinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.